Your browser doesn't support javascript.
loading
Multicentric development and evaluation of [18F]FDG PET/CT and CT radiomic models to predict regional and/or distant recurrence in early-stage non-small cell lung cancer treated by stereotactic body radiation therapy.
Lucia, François; Louis, Thomas; Cousin, François; Bourbonne, Vincent; Visvikis, Dimitris; Mievis, Carole; Jansen, Nicolas; Duysinx, Bernard; Le Pennec, Romain; Nebbache, Malik; Rehn, Martin; Hamya, Mohamed; Geier, Margaux; Salaun, Pierre-Yves; Schick, Ulrike; Hatt, Mathieu; Coucke, Philippe; Hustinx, Roland; Lovinfosse, Pierre.
Afiliação
  • Lucia F; Radiation Oncology Department, University Hospital, Brest, France. francois.lucia@chu-brest.fr.
  • Louis T; LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France. francois.lucia@chu-brest.fr.
  • Cousin F; Division of Nuclear Medicine and Oncological Imaging, University Hospital of Liège, Liège, Belgium. francois.lucia@chu-brest.fr.
  • Bourbonne V; Service de Radiothérapie, CHRU Morvan, 2 Avenue Foch, 29609 Cedex, Brest, France. francois.lucia@chu-brest.fr.
  • Visvikis D; Division of Nuclear Medicine and Oncological Imaging, University Hospital of Liège, Liège, Belgium.
  • Mievis C; Division of Nuclear Medicine and Oncological Imaging, University Hospital of Liège, Liège, Belgium.
  • Jansen N; Radiation Oncology Department, University Hospital, Brest, France.
  • Duysinx B; LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.
  • Le Pennec R; LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.
  • Nebbache M; Department of Radiotherapy Oncology, University Hospital of Liège, Liège, Belgium.
  • Rehn M; Department of Radiotherapy Oncology, University Hospital of Liège, Liège, Belgium.
  • Hamya M; Division of Pulmonology, CHU Liège, Liège, Belgium.
  • Geier M; Nuclear Medicine Department, University Hospital, Brest, France.
  • Salaun PY; GETBO, INSERM, UMR 1304, University of Brest, UBO, Brest, France.
  • Schick U; Radiation Oncology Department, University Hospital, Brest, France.
  • Hatt M; Radiation Oncology Department, University Hospital, Brest, France.
  • Coucke P; Radiation Oncology Department, University Hospital, Brest, France.
  • Hustinx R; Medical Oncology Department, University Hospital, Brest, France.
  • Lovinfosse P; Nuclear Medicine Department, University Hospital, Brest, France.
Eur J Nucl Med Mol Imaging ; 51(4): 1097-1108, 2024 Mar.
Article em En | MEDLINE | ID: mdl-37987783
ABSTRACT

PURPOSE:

To develop machine learning models to predict regional and/or distant recurrence in patients with early-stage non-small cell lung cancer (ES-NSCLC) after stereotactic body radiation therapy (SBRT) using [18F]FDG PET/CT and CT radiomics combined with clinical and dosimetric parameters.

METHODS:

We retrospectively collected 464 patients (60% for training and 40% for testing) from University Hospital of Liège and 63 patients from University Hospital of Brest (external testing set) with ES-NSCLC treated with SBRT between 2010 and 2020 and who had undergone pretreatment [18F]FDG PET/CT and planning CT. Radiomic features were extracted using the PyRadiomics toolbox®. The ComBat harmonization method was applied to reduce the batch effect between centers. Clinical, radiomic, and combined models were trained and tested using a neural network approach to predict regional and/or distant recurrence.

RESULTS:

In the training (n = 273) and testing sets (n = 191 and n = 63), the clinical model achieved moderate performances to predict regional and/or distant recurrence with C-statistics from 0.53 to 0.59 (95% CI, 0.41, 0.67). The radiomic (original_firstorder_Entropy, original_gldm_LowGrayLevelEmphasis and original_glcm_DifferenceAverage) model achieved higher predictive ability in the training set and kept the same performance in the testing sets, with C-statistics from 0.70 to 0.78 (95% CI, 0.63, 0.88) while the combined model performs moderately well with C-statistics from 0.50 to 0.62 (95% CI, 0.37, 0.69).

CONCLUSION:

Radiomic features extracted from pre-SBRT analog and digital [18F]FDG PET/CT outperform clinical parameters in the prediction of regional and/or distant recurrence and to discuss an adjuvant systemic treatment in ES-NSCLC. Prospective validation of our models should now be carried out.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radiocirurgia / Carcinoma Pulmonar de Células não Pequenas / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Assunto da revista: MEDICINA NUCLEAR Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radiocirurgia / Carcinoma Pulmonar de Células não Pequenas / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Assunto da revista: MEDICINA NUCLEAR Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França